Jorge-Antonio Lopez

ORCID: 0000-0003-2109-0001
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • CRISPR and Genetic Engineering
  • DNA Repair Mechanisms
  • RNA modifications and cancer
  • Cancer Genomics and Diagnostics
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • RNA and protein synthesis mechanisms
  • PARP inhibition in cancer therapy
  • Fibroblast Growth Factor Research
  • Bladder and Urothelial Cancer Treatments
  • Epigenetics and DNA Methylation

Roche (Switzerland)
2021-2022

To study associations across tumor types between genome-wide loss of heterozygosity (gLOH) and alterations in homologous recombination repair (HRR)-associated genes beyond BRCA1 BRCA2.

10.1158/1078-0432.ccr-21-2096 article EN cc-by-nc-nd Clinical Cancer Research 2021-11-04

<div>AbstractPurpose:<p>To study associations across tumor types between genome-wide loss of heterozygosity (gLOH) and alterations in homologous recombination repair (HRR)-associated genes beyond <i>BRCA1</i> <i>BRCA2</i>.</p>Experimental Design:<p>Genomic profiling using a targeted next-generation sequencing assay examining 324–465 (FoundationOne, FoundationOne Heme, CDx; Foundation Medicine, Inc.) was performed cohort 160,790 samples...

10.1158/1078-0432.c.6531128 preprint EN 2023-03-31

<div>AbstractPurpose:<p>To study associations across tumor types between genome-wide loss of heterozygosity (gLOH) and alterations in homologous recombination repair (HRR)-associated genes beyond <i>BRCA1</i> <i>BRCA2</i>.</p>Experimental Design:<p>Genomic profiling using a targeted next-generation sequencing assay examining 324–465 (FoundationOne, FoundationOne Heme, CDx; Foundation Medicine, Inc.) was performed cohort 160,790 samples...

10.1158/1078-0432.c.6531128.v1 preprint EN 2023-03-31
Coming Soon ...